key: cord-0726549-thjoj2fz
authors: Lu, Lu; Xiong, Weixi; Mu, Jie; Zhang, Qi; Zhang, Hesheng; Zou, Ling; Li, Weimin; He, Li; Sander, Josemir W.; Zhou, Dong
title: Neurological side effects of COVID‐19 vaccines are rare
date: 2021-05-17
journal: Acta Neurol Scand
DOI: 10.1111/ane.13444
sha: 9df3c5613af8383046c48d22e550e86eee9701a2
doc_id: 726549
cord_uid: thjoj2fz

nan

There is also new evidence in the mRNA platform. Aside from the published phase 3 trials, real-world data 6 showed a similar number of neurological events between vaccinated and unvaccinated populations. Other safety results are also consistent with the extensive safety and tolerability assessments conducted in Phase 1/2 and Phase 3 trials. The Advisory Committee on Immunization Practices (ACIP) of the CDC also presented similar data compared to the unvaccinated group. No statistical signals were detected for Bell's palsy, convulsions/seizures, hemorrhagic or ischemic stroke, and venous thromboembolism. 7 Despite the limitation of neurological adverse events reporting, public media showed a few cases of people with continuous trunk movements and limbs or walking difficulties. 8 These reports were considered mainly as functional neurological disorders. The causality between these symptoms and vaccination was uncertain.

Based on the current evidence, though more neurological adverse effects were reported with the massive worldwide vaccination, the causality is yet to be confirmed. As the vaccinated population increases, inevitable more neurological incidents will be seen. The link between them and the vaccine association will need to be tested by comparing their incidence rate with epidemiological data preceding the pandemic. We agree that it is essential to establish a transparent and efficient reporting system of vaccination safety. This will require full collaboration between regulators, healthcare workers, the industry, and the general public.

adverse effect, blood blot, safety, SARS-CoV-2 

The authors report no conflicts of interest in relation to this work. 

The potential neurological effect of the COVID-19 vaccines: a review

Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots

Vaccine AstraZeneca)-Safety updates 2021

Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?

Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA vaccines for COVID-19 from Moderna and Pfizer/BioNtech

ACIP presentation slides

Helping the public understand adverse events associated with COVID-19 vaccinations: lessons learned from functional neurological disorder